This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.
CLSI POCT14
Original price was: $180.00.$90.00Current price is: $90.00.
Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE
Clinical and Laboratory Standards Institute , 07/27/2020
Pages: 68
